Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy

BACKGROUND: Direct-acting antivirals (DAAs) targeting hepatitis C virus (HCV) have revolutionized outcomes in human immunodeficiency virus (HIV) coinfection. METHODS: We examined early events in liver and plasma through A5335S, a substudy of trial A5329 (paritaprevir/ritonavir, ombitasvir, dasabuvir...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Balagopal, Ashwin, Smeaton, Laura M, Quinn, Jeffrey, Venuto, Charles S, Morse, Gene D, Vu, Vincent, Alston-Smith, Beverly, Cohen, Daniel E, Santana-Bagur, Jorge L, Anthony, Donald D, Sulkowski, Mark S, Wyles, David L, Talal, Andrew H
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7377286/
https://ncbi.nlm.nih.gov/pubmed/32201883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa126
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars